MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-20 |
Device Problems
Break (1069); Insufficient Flow or Under Infusion (2182); Material Integrity Problem (2978)
|
Patient Problems
Cramp(s) (2193); Therapeutic Response, Decreased (2271); No Code Available (3191)
|
Event Date 10/30/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8780, serial# (b)(4), product type: catheter.Information references the main component of the system.Other relevant device(s) are: product id: 8780, serial/lot #: (b)(4), ubd: (b)(6) 2018, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from a company representative (rep) regarding a patient receiving an unknown intrathecal medication via an implanted pump for intractable spasticity.The patient felt like their leg cramps up about once a month.It was noted the healthcare provider (hcp) had checked the pump logs each time during the refills and had not found an issue with the pump.The rep had also read the pump logs and there were no anomalies.At this point, the healthcare provider (hcp) was not going to replace the pump if there was no issue with it.The rep would follow-up with the hcp.The event date was 2017 (about 5 months ago).No further complications were reported/anticipated or expected.Additional information was received from a healthcare provider (hcp) via the manufacturing representative (rep) on (b)(6) 2018.It was reported device had been delivering compounded baclofen, with an unknown dose and concentration.The rep had been told by the hcp that the pump had been working well for the first year to 14 months after implant.Since then, the patient had been experiencing "episodic incidences" where the patient would present with withdrawal symptoms.The hcp would supplement with oral baclofen and the patient would return to normal, before it would start over again.The rep planned to follow-up with the hcp.The pump logs showed no problems and the hcp said the catheter had "aspirated fine" when they accessed the catheter access port (cap).It was reviewed there was the option to check the pump reservoir for accuracy and the option of doing a dye study.It was reviewed the hcp could consider non-system causes.It was indicated the symptoms had begun over the past 4-5 months.Additional information was received from a health care provider (hcp) via a device manufacturer representative on (b)(6) 2018.It was reported that the doctor performed a catheter revision and a pump replacement on (b)(6) 2018.A small piece of the catheter was sheared near the pump connector.That section of the catheter was replaced.The new catheter aspirated freely.There were no known environmental, external or patient factors which may have led or contributed to the issue.It was unknown if the issue was resolved.No further complications were reported.
|
|
Manufacturer Narrative
|
Analysis results were not available at the time of this report.A follow-up report will be sent when analysis is completed.The returned pump was interrogated and as per the logs the following medications were being administered as of (b)(6) 2018: baclofen with concentration 1 ,500.0 mcg/ml at dose rate of 511.4 mcg/day, and morphine with concentration 1,500.0 mcg/ml at a dose rate of 511.4 mcg/day.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The pump and catheter were returned to the manufacturer for analysis.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Evaluation of implantable pump (b)(4) revealed underinfusion in the lab with an undetermined root cause.Evaluation of implantable catheter (b)(4) revealed damage to the transition tubing.The catheter was found to be patent, and passed pressure leak testing in the lab.(b)(4).If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|